Company intelligence / Profile preview
Dexon Biotech
- Ownership
- Private
- Development stage
- Other
Overview
Dexon Biotech is an Indian pharmaceutical company focused on the manufacturing and marketing of a wide range of generic pharmaceutical formulations. The company's product portfolio includes antibiotics, analgesics, anti-inflammatory drugs, and treatments for gastrointestinal and respiratory conditions. Dexon Biotech operates primarily as a commercial-stage entity, providing affordable healthcare solutions through various dosage forms such as tablets, capsules, and injectables. They emphasize quality control and compliance with regional regulatory standards to serve the domestic Indian market.
- Therapeutic areas
- Infectious DiseasesGastroenterologyNeurologyImmunology
- Modalities
- Small molecule
- Industry
- Pharma
Drug pipeline
1 assetBeyond the preview
Go deeper on Dexon Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dexon Biotech.